Cargando…
Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer
BACKGROUND: To investigate the value of using contrast-enhanced transrectal ultrasound (CETRUS) to reduce unnecessary collection of biopsies during prostate cancer diagnosis and its utility in predicting biochemical recurrence in patients with localized prostate cancer. METHODS: This was a prospecti...
Autores principales: | Zhao, Hong-wei, Li, Jian, Cao, Jia-Zheng, Lin, Juan, Wang, Zhu, Lv, Jian-yao, Wei, Jin-huan, Chen, Zhen-hua, Yao, Hao-hua, Pan, Yi-hui, Gao, Zhen-li, Luo, Jun-hang, Chen, Wei, Shi, Lei, Fang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364623/ https://www.ncbi.nlm.nih.gov/pubmed/32677927 http://dx.doi.org/10.1186/s12894-020-00659-6 |
Ejemplares similares
-
Transrectal ultrasound examination of prostate cancer guided by fusion imaging of multiparametric MRI and TRUS: avoiding unnecessary mpMRI-guided targeted biopsy
por: Xu, Guang, et al.
Publicado: (2022) -
Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study
por: Pereira, Renan A, et al.
Publicado: (2015) -
Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer
por: Zhu, Sha, et al.
Publicado: (2019) -
Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer
por: Jin, Kun, et al.
Publicado: (2019) -
WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy
por: Lin, Chia-Yen, et al.
Publicado: (2023)